NFH / New Frontier Health Corporation - Class A - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

مؤسسة الصحة الحدودية الجديدة - الفئة أ
US ˙ NYSE
هذا الرمز لم يعد نشطا

الإحصائيات الأساسية
CIK 1737422
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to New Frontier Health Corporation - Class A
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
February 11, 2022 SC 13G/A

NFH / New Frontier Health Corp / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* New Frontier Health Corp. (Name of Issuer) Common Stock (Title of Class of Securities) G6461G106 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t

February 7, 2022 15-12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38562 NEW FRONTIER HEALTH CORPORATION (Exact name of registrant as specif

January 31, 2022 SC 13D/A

NFH / New Frontier Health Corp / GOLDMAN SACHS GROUP INC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* New Frontier Health Corporation (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G106 (CUSIP Number) David S. Thomas, Esq. Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 (212) 902-1000 With a copy to: Mark H. Lucas, Esq.

January 28, 2022 S-8 POS

As filed with the United States Securities and Exchange Commission on January 28, 2022

As filed with the United States Securities and Exchange Commission on January 28, 2022 Registration No.

January 28, 2022 POS AM

As filed with the United States Securities and Exchange Commission on January 28, 2022

As filed with the United States Securities and Exchange Commission on January 28, 2022 Registration No.

January 27, 2022 SC 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 2 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 NEW FRONTIER HEALTH CORPORATION (Name of the Issuer) Ne

SC 13E3/A 1 tm224425-1sc13e3a.htm SC 13E3/A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 2 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 NEW FRONTIER HEALTH CORPORATION (Name of the Issuer) New Frontier Health Corporation Unicorn II Holdings Limited Unicorn II Parent Limited Unic

January 27, 2022 EX-99.25

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 07, 2022, pursuant to the provisions of Rule 12d2-2 (a).

January 27, 2022 SC 13D/A

NFH / New Frontier Health Corp / New Frontier Public Holding Ltd. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. Unit 3004, Garden Square, No. 968, Beijing West Road, Jing?An, Shanghai, China 852-3703-325

January 26, 2022 EX-99.1

New Frontier Health Corporation Announces Completion of Going Private Transaction

Exhibit 99.1 New Frontier Health Corporation Announces Completion of Going Private Transaction BEIJING, China ? January 26, 2022 ? New Frontier Health Corporation (?NFH? or the ?Company?) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced the completion of its merger (the ?Merger?) with Unicorn II Merger Sub Limited (?Merger Sub?), pursuant

January 26, 2022 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100

January 11, 2022 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100

January 11, 2022 EX-99.1

New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021

Exhibit 99.1 New Frontier Health Corporation Receives Notification from NYSE Regarding Delayed Filing of Semi-Annual Financial Information for the Half Year Ended June 30, 2021 BEIJING, China, January 11, 2022 ? New Frontier Health Corporation (NYSE: NFH) (?NFH? or the ?Company?), the operator of the premium healthcare services provider United Family Healthcare, today reported that, on January 4,

January 7, 2022 EX-99.1

New Frontier Health Corporation Announces Shareholders’ Approval of Merger Agreement and Warrantholders’ Approval of Warrant Amendment

Exhibit 99.1 New Frontier Health Corporation Announces Shareholders’ Approval of Merger Agreement and Warrantholders’ Approval of Warrant Amendment BEIJING, China – January 7, 2022 – New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that, at an extraordinary general meeting (the “EGM”

January 7, 2022 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2022 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100

January 7, 2022 EX-99.2

AMENDMENT NO. 1 TO WARRANT AGREEMENT

Exhibit 99.2 AMENDMENT NO. 1 TO WARRANT AGREEMENT THIS AMENDMENT NO. 1 TO WARRANT AGREEMENT (this ?Amendment?) is made as of January 6, 2022, by and between New Frontier Health Corporation (formerly known as New Frontier Corporation), a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?W

December 2, 2021 EX-99.1

New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders and Solicitation for Warrantholder Consent

Exhibit 99.1 New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders and Solicitation for Warrantholder Consent BEIJING, China ? December 2, 2021 ? New Frontier Health Corporation (?NFH? or the ?Company?) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that it has called an extraordinary general meeting of

December 2, 2021 EX-99.(D)(18)

Rollover Agreement, dated December 2, 2021, by and among HoldCo, HMJ Holdings III Limited and certain other parties therein.

Exhibit (d)-(18) EXECUTION VERSION ROLLOVER AGREEMENT This ROLLOVER AGREEMENT (this ?Agreement?) is made and entered into as of December 2, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?), HMJ Holdings III Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Rollover Vehicle?), and certain shareholders of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Company?), listed on Schedule A hereto (each, a ?Shareholder? and collectively, the ?Shareholders?).

December 2, 2021 EX-99.11

ROLLOVER AGREEMENT

Exhibit 99.11 ROLLOVER AGREEMENT This ROLLOVER AGREEMENT (this ?Agreement?) is made and entered into as of December 2, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?), HMJ Holdings III Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Roll

December 2, 2021 EX-99.9

FACILITIES AGREEMENT DATED 1 December 2021

Exhibit 99.9 PRIVATE AND CONFIDENTIAL EXECUTION VERSION FACILITIES AGREEMENT DATED 1 December 2021 for UNICORN II MERGER SUB LIMITED as Company arranged by CHINA MERCHANTS BANK CO., LTD., SHANGHAI BRANCH (??????????????) AND SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. PUTUO SUB-BRANCH (??????????????????) with SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. PUTUO SUB-BRANCH (??????????????????) as Agent

December 2, 2021 SC 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 1 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 NEW FRONTIER HEALTH CORPORATION (Name of the Issuer) Ne

SC 13E3/A 1 tm2128451-3sc13e3a.htm SC 13E3/A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 AMENDMENT NO. 1 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 NEW FRONTIER HEALTH CORPORATION (Name of the Issuer) New Frontier Health Corporation Unicorn II Holdings Limited Unicorn II Parent Limited Uni

December 2, 2021 EX-99.(A)(1)

Agreement and Plan of Merger, dated August 4, 2021, by and among the Company, HoldCo, Parent and Merger Sub, incorporated herein by reference to Annex A to the proxy statement.

TABLE OF CONTENTS PROXY AND CONSENT SOLICITATION STATEMENT OF THE COMPANY Exhibit (a)-(1)? December 2, 2021? Shareholders and Warrantholders of New Frontier Health Corporation Re: Notice of Extraordinary General Meeting of Shareholders and Notice of Consent Solicitation for Warrantholders Dear Shareholders and Warrantholders: On August 4, 2021, New Frontier Health Corporation (the ?Company?) enter

December 2, 2021 EX-99.10

SECOND AMENDMENT AND RESTATEMENT DEED DATED 1 December 2021 NF UNICORN CHINDEX HOLDING LIMITED as Company CHINDEX INTERNATIONAL INC. as Guarantor CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH AND SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. PUTUO SUB

Exhibit 99.10 PRIVATE AND CONFIDENTIAL EXECUTION VERSION SECOND AMENDMENT AND RESTATEMENT DEED DATED 1 December 2021 for NF UNICORN CHINDEX HOLDING LIMITED as Company CHINDEX INTERNATIONAL INC. as Guarantor CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH AND SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. PUTUO SUB-BRANCH (??????????????????) as Lenders and SHANGHAI PUDONG DEVELOPMENT BANK CO., LTD. PU

December 2, 2021 SC 13D/A

NFH / New Frontier Health Corp / New Frontier Public Holding Ltd. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. Unit 3004, Garden Square, No. 968, Beijing West Road, Jing?An, Shanghai, China 852-3703-325

December 2, 2021 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December 2021 Commission File Number: 001-38562 NEW FRONTIER

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 10

October 5, 2021 EX-99.9

ROLLOVER AGREEMENT

Exhibit 99.9 EXECUTION VERSION ROLLOVER AGREEMENT This ROLLOVER AGREEMENT (this ?Agreement?) is made and entered into as of October 5, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?), HMJ Holdings III Limited, an exempted company incorporated with limited liability under the laws of the Cayman Is

October 5, 2021 EX-99.(B)(8)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Pleiad Asia Master Fund, Pleiad Asia Equity Master Fund and HoldCo.

Exhibit 99.(b)(8) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

October 5, 2021 EX-99.(D)(7)

Limited Guarantee, dated August 4, 2021, issued and delivered by WSCP VIII EMP Onshore Investments, L.P., WSCP VIII EMP Offshore Investments, L.P., West Street Capital Partners VIII, L.P., West Street Capital Partners VIII — Parallel, L.P., WSCP VIII Offshore Investments, SLP, Goldman Sachs Asia Strategic II Pte. Ltd. and West Street Private Markets 2021, L.P. to the Company.

Exhibit 99.(d)(7) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by guarantors as set forth in column ?Guarantor? in Schedule A hereto (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Is

October 5, 2021 EX-99.(D)(6)

Limited Guarantee, dated August 4, 2021, issued and delivered by Yunqi China Special Investment A to the Company.

Exhibit 99.(d)(6) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Yunqi China Special Investment A (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed Party?). Ea

October 5, 2021 EX-99.(D)(5)

Limited Guarantee, dated August 4, 2021, issued and delivered by Aspex Master Fund to the Company.

Exhibit 99.(d)(5) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Aspex Master Fund (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed Party?). Each capitalized

October 5, 2021 EX-99.(D)(13)

Limited Guarantee, dated August 4, 2021, issued and delivered by NewQuest Asia Fund IV (Singapore) Pte. Ltd. to the Company.

Exhibit 99.(d)(13) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by NewQuest Asia Fund IV (Singapore) Pte. Ltd. (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed

October 5, 2021 EX-99.(D)(10)

Limited Guarantee, dated August 4, 2021, issued and delivered by Yi Fang Da Sirius Inv. Limited to the Company.

Exhibit 99.(d)(10) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Yi Fang Da Sirius Inv. Limited (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed Party?). Eac

October 5, 2021 EX-99.(B)(12)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Yunqi China Special Investment A and HoldCo.

Exhibit 99.(b)(12) EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Unicorn II Holdings

October 5, 2021 EX-99.(B)(10)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Unicorn Holding Partners LP and HoldCo.

Exhibit 99.(b)(10) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among U

October 5, 2021 SC 13E3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 RULE 13e-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 NEW FRONTIER HEALTH CORPORATION (Name of the Issuer) New Frontier Healt

TABLE OF CONTENTS ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

October 5, 2021 EX-99.(D)(8)

Limited Guarantee, dated August 4, 2021, issued and delivered by Warburg Entities to the Company.

Exhibit 99.(d)(8) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by the guarantors in column ?Guarantor? of Schedule A hereto (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (th

October 5, 2021 EX-99.(B)(11)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Warburg Pincus (Callisto) Global Growth (Cayman), L.P., Warburg Pincus (Europa) Global Growth (Cayman), L.P., Warburg Pincus Global Growth-B (Cayman), L.P., Warburg Pincus Global Growth-E (Cayman), L.P., Warburg Pincus Global Growth Partners (Cayman), L.P., WP Global Growth Partners (Cayman), L.P., Warburg Pincus China-Southeast Asia II (Cayman), L.P., Warburg Pincus China-Southeast Asia II-E (Cayman), L.P., WP China-Southeast Asia II Partners (Cayman), L.P. and Warburg Pincus China-Southeast Asia II Partners, L.P. (collectively, “Warburg Entities”) and HoldCo.

Exhibit 99.(b)(11) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among U

October 5, 2021 EX-99.(B)(4)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Yi Fang Da Sirius Inv. Limited and HoldCo.

Exhibit 99.(b)(4) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

October 5, 2021 EX-99.(D)(17)

Rollover Agreement, dated October 5, 2021, by and among HoldCo, HMJ Holdings III Limited and certain other parties therein.

Exhibit 99.(d)(17) EXECUTION VERSION ROLLOVER AGREEMENT This ROLLOVER AGREEMENT (this ?Agreement?) is made and entered into as of October 5, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?), HMJ Holdings III Limited, an exempted company incorporated with limited liability under the laws of the Cay

October 5, 2021 EX-99.(A)(1)

Agreement and Plan of Merger, dated August 4, 2021, by and among the Company, HoldCo, Parent and Merger Sub, incorporated herein by reference to Annex A to the proxy statement.

TABLE OF CONTENTS PROXY AND CONSENT SOLICITATION STATEMENT OF THE COMPANY Exhibit (a)-(1)? ???????? ??, 2021? Shareholders and Warrantholders of New Frontier Health Corporation Re: Notice of Extraordinary General Meeting of Shareholders and Notice of Consent Solicitation for Warrantholders Dear Shareholders and Warrantholders: On August 4, 2021, New Frontier Health Corporation (the ?Company?) ente

October 5, 2021 EX-99.(B)(9)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Proprium Real Estate Special Situations Fund, LP and HoldCo.

Exhibit 99.(b)(9) EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Unicorn II Holdings

October 5, 2021 EX-99.(D)(11)

Limited Guarantee, dated August 4, 2021, issued and delivered by Gaorong Partners Fund V, L.P. and Gaorong Partners Fund V-A, L.P. to the Company.

Exhibit 99.(d)(11) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Gaorong Partners Fund V, L.P. and Gaorong Partners Fund V-A, L.P. (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Is

October 5, 2021 EX-99.(D)(4)

Limited Guarantee, dated August 4, 2021, issued and delivered by Unicorn Holding Partners LP to the Company.

Exhibit 99.(d)(4) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Unicorn Holding Partners LP (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed Party?). Each ca

October 5, 2021 EX-99.(D)(9)

Limited Guarantee, dated August 4, 2021, issued and delivered by Proprium Real Estate Special Situations Fund, LP to the Company.

Exhibit 99.(d)(9) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Proprium Real Estate Special Situations Fund, LP (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaran

October 5, 2021 EX-99.(B)(7)

Equity Commitment Letter, dated August 4, 2021, entered into by and between NewQuest Asia Fund IV (Singapore) Pte. Ltd. and HoldCo.

Exhibit 99.(b)(7) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

October 5, 2021 EX-99.(D)(16)

Management Rollover Agreement, dated October 5, 2021, by and among HoldCo, HMJ Holdings II Limited and certain other parties therein.

Exhibit 99.(d)(16) EXECUTION VERSION MANAGEMENT ROLLOVER AGREEMENT This MANAGEMENT ROLLOVER AGREEMENT (this ?Agreement?) is made and entered into as of October 5, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?), HMJ Holdings II Limited, an exempted company incorporated with limited liability unde

October 5, 2021 EX-99.(D)(12)

Limited Guarantee, dated August 4, 2021, issued and delivered by Pleiad Asia Master Fund and Pleiad Asia Equity Master Fund to the Company.

Exhibit 99.(d)(12) EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by Pleiad Asia Master Fund and Pleiad Asia Equity Master Fund (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (

October 5, 2021 EX-99.(B)(5)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Gaorong Partners Fund V, L.P., Gaorong Partners Fund V-A, L.P. and HoldCo.

Exhibit 99.(b)(5) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

October 5, 2021 EX-99.10

JOINT FILING AGREEMENT

Exhibit 99.10 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the ?Exchange Act?) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, resta

October 5, 2021 EX-99.8

Management Rollover Agreement, dated October 5, 2021, by and among HoldCo, HMJ II and each Management Rollover Securityholder

EX-99.8 2 tm2128436d1ex99-8.htm EXHIBIT 99.8 Exhibit 99.8 MANAGEMENT ROLLOVER AGREEMENT This MANAGEMENT ROLLOVER AGREEMENT (this “Agreement”) is made and entered into as of October 5, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“HoldCo”), HMJ Holdings II Limited, an exempted company incorporated with l

October 5, 2021 EX-99.(B)(3)

Equity Commitment Letter, dated August 4, 2021, entered into by and between Aspex Master Fund and HoldCo.

Exhibit 99.(b)(3) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

October 5, 2021 SC 13D/A

NFH / New Frontier Health Corp / New Frontier Public Holding Ltd. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. Unit 3004, Garden Square, No. 968, Beijing West Road, Jing?An, Shanghai, China 852-3703-325

October 5, 2021 EX-99.(C)(2)

Discussion Materials prepared by Duff & Phelps A Kroll Business operating as Kroll, LLC for discussion with the special committee of the board of directors of the Company, dated August 4, 2021.

Exhibit 99.(c)(2) New Frontier Health Corporation Confidential Fairness Analysis Presented to the Special Committee of Independent Directors August 4, 2021 The information contained herein is of a confidential nature and is intended for the use of the persons or firm to whom it is furnished by us. Reproduction, publication, or dissemination of any portion hereof may not be made without prior appro

October 5, 2021 EX-99.(B)(6)

Partners VIII, L.P., West Street Capital Partners VIII — Parallel, L.P., WSCP VIII Offshore Investments, SLP, Goldman Sachs Asia Strategic II Pte. Ltd., West Street Private Markets 2021, L.P. and HoldCo.

Exhibit 99.(b)(6) EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the ?Merger Agreement?), by and among Un

August 16, 2021 EX-24

EX-24

EX-24 2 ff43273513d-ex24.htm

August 16, 2021 SC 13D

NFH / New Frontier Health Corp / GOLDMAN SACHS GROUP INC Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* New Frontier Health Corporation (Name of Issuer) Class A Shares (Title of Class of Securities) G6461G106 (CUSIP Number) David S. Thomas, Esq. Goldman Sachs & Co. LLC 200 West Street New York, NY 10282 (212) 902-1000 With a copy to: Mark H. Lucas, Esq. Fri

August 6, 2021 EX-99.4

Debt Commitment Letter, dated June 25, 2021, by and among Merger Sub and CMB

EX-99.4 5 tm2124278d1ex99-4.htm EXHIBIT 99.4 Exhibit 99.4 To: Unicorn II Merger Sub Limited (you or the Company) June 25, 2021 Dear Sirs, Project Unicorn II – Commitment Letter We, China Merchants Bank Shanghai Branch (the Original Arranger) and China Merchants Bank Shanghai Branch (the Original Underwriter, and together with the Original Arranger, we or us) are pleased to set out in this letter t

August 6, 2021 SC 13D/A

NFH / New Frontier Health Corp / New Frontier Public Holding Ltd. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong 852-6491-9230 Copy to: Yang Wang

August 6, 2021 EX-99.6

SUPPORT AGREEMENT

Exhibit 99.6 EXECUTION VERSION SUPPORT AGREEMENT This SUPPORT AGREEMENT (this ?Agreement?) is made and entered into as of August 4, 2021 by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (?HoldCo?) and certain shareholders of New Frontier Health Corporation, an exempted company incorporated with limited liability

August 6, 2021 EX-99.5

1

Exhibit 99.5 To:??????????Unicorn II Merger Sub Limited (you or the Company) 28 July 2021 Dear Sirs, Project Unicorn II ? Commitment Letter We, Shanghai Pudong Development Bank Co., Ltd. Putuo Sub-Branch (??????????????????) (the Original Arranger) and Shanghai Pudong Development Bank Co., Ltd. Putuo Sub-Branch (??????????????????) (the Original Underwriter, and together with the Original Arranger

August 6, 2021 EX-99.8

Joint Filing Agreement by and among the Reporting Persons

EX-99.8 9 tm2124278d1ex99-8.htm EXHIBIT 99.8 Exhibit 99.8 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulatio

August 6, 2021 EX-99.2

LIMITED GUARANTEE

Exhibit 99.2 EXECUTION VERSION LIMITED GUARANTEE This LIMITED GUARANTEE (this ?Limited Guarantee?), dated as of August 4, 2021, is made by [Guarantor 1], [Guarantor 2] and [Guarantor 3] (each a ?Guarantor,? and collectively, the ?Guarantors?) in favor of New Frontier Health Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the ?Guaranteed Pa

August 6, 2021 EX-99.3

EQUITY COMMITMENT LETTER

EX-99.3 4 tm2124278d1ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 EXECUTION VERSION EQUITY COMMITMENT LETTER August 4, 2021 Unicorn II Holdings Limited 89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands Ladies and Gentlemen: Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time,

August 6, 2021 EX-99.7

Exhibit 99.7 to the Schedule 13D

EX-99.7 8 tm2124278d1ex99-7.htm EXHIBIT 99.7 Exhibit 99.7 EXECUTION VERSION INTERIM INVESTORS AGREEMENT This INTERIM INVESTORS AGREEMENT (the “Agreement”) is made as of August 4, 2021, by and among Unicorn II Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“HoldCo”), Unicorn II Parent Limited, an exempted company incorporated with lim

August 6, 2021 EX-99.1

AGREEMENT AND PLAN OF MERGER by and among UNICORN II HOLDINGS LIMITED UNICORN II PARENT LIMITED UNICORN II MERGER SUB LIMITED NEW FRONTIER HEALTH CORPORATION Dated as of August 4, 2021 TABLE OF CONTENTS

EX-99.1 2 tm2124278d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among UNICORN II HOLDINGS LIMITED UNICORN II PARENT LIMITED UNICORN II MERGER SUB LIMITED and NEW FRONTIER HEALTH CORPORATION Dated as of August 4, 2021 TABLE OF CONTENTS Article I DEFINITIONS AND INTERPRETATION 2 Section 1.1 Certain Definitions 2 Section 1.2 Terms Defined Elsewhere 10 S

August 4, 2021 EX-99.2

AGREEMENT AND PLAN OF MERGER by and among UNICORN II HOLDINGS LIMITED UNICORN II PARENT LIMITED UNICORN II MERGER SUB LIMITED NEW FRONTIER HEALTH CORPORATION Dated as of August 4, 2021 TABLE OF CONTENTS

Exhibit 99.2 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among UNICORN II HOLDINGS LIMITED UNICORN II PARENT LIMITED UNICORN II MERGER SUB LIMITED and NEW FRONTIER HEALTH CORPORATION Dated as of August 4, 2021 TABLE OF CONTENTS Article I DEFINITIONS AND INTERPRETATION 2 Section 1.1 Certain Definitions 2 Section 1.2 Terms Defined Elsewhere 10 Section 1.3 Interpretation 12 Article II THE M

August 4, 2021 EX-99.1

New Frontier Health Corporation Enters into Definitive Merger Agreement for Going Private Transaction

Exhibit 99.1 New Frontier Health Corporation Enters into Definitive Merger Agreement for Going Private Transaction BEIJING, China, August 4th, 2021 ? New Frontier Health Corporation (?NFH? or the ?Company?) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that it has entered into a definitive Agreement and Plan of Merger (the ?Merger Agree

August 4, 2021 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2021 Commission File Number: 001-38562 NEW FRONTIER H

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 1000

June 4, 2021 EX-12.2

Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Financial Officer

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Walter Xue, certify that: 1. I have reviewed this annual report on Form 20-F of New Frontier Health Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit t

June 4, 2021 EX-13.2

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of New Frontier Health Corporation (the ?Company?) on Form 20-F for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant

June 4, 2021 EX-12.1

Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Executive Officer

Exhibit 12-1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Roberta Lipson, certify that: 1.

June 4, 2021 20-F

the Company’s Form 20-F for the fiscal year ended December 31, 2020, filed on June 4, 2021

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

June 4, 2021 EX-13.1

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of New Frontier Health Corporation (the ?Company?) on Form 20-F for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the ?Report?), the undersigned hereby certifies pursuant

May 25, 2021 EX-99.1

New Frontier Health Corporation Receives NYSE Notice Regarding Late Form 20-F Filing

Exhibit 99.1 New Frontier Health Corporation Receives NYSE Notice Regarding Late Form 20-F Filing BEIJING, CHINA, May 25, 2021 ? New Frontier Health Corporation (NYSE: NFH) today announced that, as expected, on May 18, 2021 it received a notice from the New York Stock Exchange (the ?NYSE?) that the Company was not in compliance with the NYSE?s continued listing requirements under the timely filing

May 25, 2021 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38562 NEW FRONTIER HEAL

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100015

April 30, 2021 NT 20-F

- NT 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K x Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2020 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q For the Transition Pe

April 8, 2021 6-K

Current Report of Foreign Issuer - 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of April 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 10001

April 8, 2021 EX-99.1

New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2020 Financial Results

EX-99.1 2 tm2112484d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2020 Financial Results BEIJING—April 8, 2021 /BUSINESS WIRE/ - New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced its financial results for the fourth q

April 8, 2021 EX-99.2

1 1 New Frontier Health Q4 2020 Results Apr 8, 2021

Exhibit 99.2 1 1 New Frontier Health Q4 2020 Results Apr 8, 2021 2 2 Disclaimer Forward - Looking Statements This presentation includes ?forward - looking statements? within the meaning of the ?safe harbor? provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the ?Company?) may differ from the Company?s expectations, estimates

March 31, 2021 EX-99.1

New Frontier Health to Announce Fourth Quarter and Fiscal Year 2020 Financial Results on April 8, 2021

Exhibit 99.1 New Frontier Health to Announce Fourth Quarter and Fiscal Year 2020 Financial Results on April 8, 2021 March 31, 2021 07:30 AM Eastern Daylight Time BEIJING-(BUSINESS WIRE)-New Frontier Health Corporation (?NFH? or ?the Company?) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (UFH), today announced that it plans to release its fourth quarter

March 31, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 10001

March 18, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant?s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 10001

March 18, 2021 424B3

NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants

Filed pursuant to Rule 424(b)(3) Registration No. 333-236079 Prospectus Supplement No. 5 (to Prospectus dated April 8, 2020) NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants This Prospectus Supplement No. 5 supplements our Prospectus dated April 8, 2020 (the ?Prospectus?) that forms a part of our Re

March 18, 2021 EX-99.1

New Frontier Health Corporation Announces Formation of Special Committee and Appointment of Advisors

Exhibit 99.1 New Frontier Health Corporation Announces Formation of Special Committee and Appointment of Advisors March 18, 2021 08:00 AM Eastern Daylight Time BEIJING-(BUSINESS WIRE)-New Frontier Health Corporation (?NFH? or the ?Company?) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare, today announced that its board of directors (the ?Board?) has forme

February 16, 2021 EX-99.1

Exhibit 1 to the Schedule 13D

Exhibit 1 Execution Version CONSORTIUM AGREEMENT Dated as of February 9, 2021 TABLE OF CONTENTS Page Article I DEFINITIONS AND INTERPRETATIONS 4 Section 1.

February 16, 2021 SC 13G/A

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* New Frontier Health Corp. (Name of Issuer) Common Stock (Title of Class of Securities) G6461G106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which t

February 16, 2021 EX-99.2

JOINT FILING AGREEMENT

EX-99.2 3 tm216312d1ex2.htm EXHIBIT 2 Exhibit 2 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereund

February 16, 2021 SC 13D/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 1

SC 13D/A 1 tm216312d1sc13d.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. 23rd Floor, 299 QRC 287-299 Queen’s Road Central Ho

February 10, 2021 EX-99.1

New Frontier Health Corporation Announces Receipt of Preliminary Non-Binding “Going Private” Proposal

Exhibit 99.1 New Frontier Health Corporation Announces Receipt of Preliminary Non-Binding “Going Private” Proposal BEIJING, China, February 10, 2021 /PRNewswire/ — New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH”), today announced that its board of directors (the “Board”) has received a prelim

February 10, 2021 EX-99.2

New Frontier Health Corporation Announces Receipt of Clarification to Preliminary Non-Binding “Going Private” Proposal

EX-99.2 3 tm216068d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 New Frontier Health Corporation Announces Receipt of Clarification to Preliminary Non-Binding “Going Private” Proposal BEIJING-(BUSINESS WIRE)-New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH”), today announced that, following its announc

February 10, 2021 424B3

NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants

Filed pursuant to Rule 424(b)(3) Registration No. 333-236079 Prospectus Supplement No. 4 (to Prospectus dated April 8, 2020) NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants This Prospectus Supplement No. 4 supplements our Prospectus dated April 8, 2020 (the “Prospectus”) that forms a part of our Re

February 10, 2021 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February 2021 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 10

December 2, 2020 424B3

NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants

Filed pursuant to rule 424(b)(3) Registration No. 333-236079 Prospectus Supplement No. 3 (to Prospectus dated April 8, 2020) NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants This Prospectus Supplement No. 3 supplements our Prospectus dated April 8, 2020 (the “Prospectus”) that forms a part of our Re

December 2, 2020 EX-99.1

New Frontier Health Corporation Announces Third Quarter 2020 Financial Results

EX-99.1 2 tm2037472d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Health Corporation Announces Third Quarter 2020 Financial Results BEIJING, China, December 2, 2020 /Business Wire/ - New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced its unaudited financial results for the

December 2, 2020 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 1

December 2, 2020 EX-99.2

1 1 New Frontier Health Q3 2020 Results Dec 2, 2020

Exhibit 99.2 1 1 New Frontier Health Q3 2020 Results Dec 2, 2020 2 2 Disclaimer Forward - Looking Statements This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the “Company”) may differ from the Company’s expectations, estimates

August 27, 2020 EX-99.2

1 1 New Frontier Health Q2 2020 Results Aug 27, 2020

EX-99.2 3 tm2029465d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 1 1 New Frontier Health Q2 2020 Results Aug 27, 2020 2 2 Disclaimer Forward - Looking Statements This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the “Company”) may diff

August 27, 2020 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100

August 27, 2020 EX-99.1

New Frontier Health Corporation Announces Second Quarter 2020 Financial Results

Exhibit 99.1 New Frontier Health Corporation Announces Second Quarter 2020 Financial Results BEIJING, China, August 27, 2020 /Business Wire/ - New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced its unaudited financial results for the second quarter ended June 30, 2020. Financia

August 27, 2020 424B3

NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants

Filed pursuant to rule 424(b)(3) Registration No. 333-236079 Prospectus Supplement No. 2 (to Prospectus dated April 8, 2020) NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants This Prospectus Supplement No. 2 supplements our Prospectus dated April 8, 2020 (the “Prospectus”) that forms a part of our Re

August 17, 2020 S-8

- FORM S-8

As filed with the United States Securities and Exchange Commission on August 17, 2020 Registration No.

August 3, 2020 6-K

Current Report of Foreign Issuer - 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of August, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100

August 3, 2020 EX-99.1

New Frontier Health Corporation Announces Executive Management Team Changes

Exhibit 99.1 New Frontier Health Corporation Announces Executive Management Team Changes BEIJING — August 3, 2020 - New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced executive management team changes effective August 1, 2020. The Company’s Board of Directors (the “Board”) has

May 27, 2020 424B3

NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants

Filed pursuant to rule 424(b)(3) Registration No. 333-236079 Prospectus Supplement No. 1 (to Prospectus dated April 8, 2020) NEW FRONTIER HEALTH CORPORATION Primary Offering of 26,875,000 Ordinary Shares Secondary Offering of 127,341,048 Ordinary Shares 12,500,000 Warrants This Prospectus Supplement No. 1 supplements our Prospectus dated April 8, 2020 (the “Prospectus”) that forms a part of our Re

May 27, 2020 EX-99.2

1 1 New Frontier Health Q1 2020 Results May 27, 2020

EX-99.2 3 tm2021018d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 1 1 New Frontier Health Q1 2020 Results May 27, 2020 2 2 Disclaimer Forward - Looking Statements This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the “Company”) may diff

May 27, 2020 EX-99.1

New Frontier Health Corporation Announces First Quarter 2020 Financial Results

EX-99.1 2 tm2021018d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Health Corporation Announces First Quarter 2020 Financial Results New Frontier Health Corporation (“NFH” or the “Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced its unaudited financial results for the first quarter ended March 31, 2020. Financial and

May 27, 2020 6-K

Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of May, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 100015

March 31, 2020 POS AM

NFC / New Frontier Corporation POS AM - - POS AM

As filed with the United States Securities and Exchange Commission on March 31, 2020 Registration No.

March 31, 2020 EX-2.5

Description of Securities.

Exhibit 2.5 DESCRIPTION OF SECURITIES The following description of the securities registered under Section 12 of the Securities Exchange Act of 1934 of New Frontier Corporation (“NFH,” “us,” “our,” “we” or the “Company”) is a summary of the material terms of our securities and certain provisions of our amended and restated memorandum and articles of association in effect as of March 31, 2020 (our

March 31, 2020 EX-13.1

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer

Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of New Frontier Health Corporation (the “Company”) on Form 20-F for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant

March 31, 2020 20-F

March 31, 2020

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC

March 31, 2020 EX-13.2

18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer

Exhibit 13.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of New Frontier Health Corporation (the “Company”) on Form 20-F for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies pursuant

March 31, 2020 EX-12.2

Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Financial Officer

Exhibit 12.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Walter Xue, certify that: 1. I have reviewed this annual report on Form 20-F of New Frontier Health Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit t

March 31, 2020 EX-12.1

Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Executive Officer

Exhibit 12-1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Roberta Lipson, certify that: 1.

March 26, 2020 EX-99.2

1 1 New Frontier Health Q4 2019 Results 26 th March 2020

EX-99.2 3 tm2013874d1ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 1 1 New Frontier Health Q4 2019 Results 26 th March 2020 2 2 DISCLAIMER Forward - Looking Statements This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the “Company”) may

March 26, 2020 6-K

NFC / New Frontier Corporation 6-K - Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 1000

March 26, 2020 EX-99.1

New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2019 Financial Results

Exhibit 99.1 New Frontier Health Corporation Announces Fourth Quarter and Fiscal 2019 Financial Results New Frontier Health Corporation (“NFH” or “the Company”) (NYSE: NFH), operator of the premium healthcare services provider United Family Healthcare (“UFH"), today announced the unaudited financial results of Healthy Harmony Holdings, L.P. and its subsidiaries (“Healthy Harmony”) for the fourth q

February 19, 2020 6-K

NFC / New Frontier Corporation 6-K - Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of February, 2020 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 10 Jiuxianqiao Road, Hengtong Business Park B7 Building, 1/F Chaoyang District, 1

February 19, 2020 EX-99.1

1 1 Introduction to New Frontier Health Corp. (NYSE: NFH) Jan 2020

EX-99.1 2 tm207242d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Introduction to New Frontier Health Corp. (NYSE: NFH) Jan 2020 2 2 DISCLAIMER Forward - Looking Statements This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the Private Securi ties Litigation Reform Act of 1995. The actual results of New Frontier Health Corporation (the “Compa

February 13, 2020 SC 13G/A

NFC / New Frontier Corporation / OXFORD ASSET MANAGEMENT - OXFORD ASSET MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NEW FRONTIER HEALTH CORP (Name of Issuer) Class A ordinary shares, par value $0.0001 (Title of Class of Securities) G6485P108 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate

January 28, 2020 CORRESP

NFC / New Frontier Corporation CORRESP - -

New Frontier Health Corporation 10 Jiuxianqiao Road Hengtong Business Park B7 Building, 1/F Chaoyang District, 100015 Beijing, China January 28, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance U.

January 24, 2020 EX-16.1

Letter from WithumSmith+Brown, PC.

Exhibit 16.1 January 24, 2020 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by New Frontier Health Corporation (formerly known as New Frontier Corporation) in the Registration Statement dated January 24, 2020. We agree with the statements concerning our Firm in such Registration State

January 24, 2020 F-1

NFC / New Frontier Corporation F-1 - - F-1

TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on January 24, 2020 Registration No.

January 2, 2020 SC 13D

NFC / New Frontier Corporation / Nan Fung Group Holdings Ltd - SCHEDULE 13D FOR NEW FRONTIER HEALTH CORPORATION BY NAN FUNG GROUP HOLDINGS LIMITED Activist Investment

SC 13D 1 s13d121819-newfrontierhlth.htm SCHEDULE 13D FOR NEW FRONTIER HEALTH CORPORATION BY NAN FUNG GROUP HOLDINGS LIMITED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Brian Tse Nan Fung Group Ho

December 30, 2019 SC 13D/A

NFC / New Frontier Corporation / New Frontier Public Holding Ltd. - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares (Title of Class of Securities) G6461G 106 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong 852-6491-9230 Copy to: Joel L. R

December 30, 2019 EX-99.4

FOSUN ROLLOVER AGREEMENT

Exhibit 99.4 FOSUN ROLLOVER AGREEMENT This FOSUN ROLLOVER AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“NFC” or the “

December 30, 2019 EX-99.1

JOINT FILING AGREEMENT

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such pe

December 30, 2019 EX-99.2

DIRECTORS AND EXECUTIVE OFFICERS OF FOSUN INDUSTRIAL AND FOSUN PHARMA

Exhibit 99.2 DIRECTORS AND EXECUTIVE OFFICERS OF FOSUN INDUSTRIAL AND FOSUN PHARMA The name, business address, present principal employment and citizenship of each director and executive officer of Fosun Industrial is set forth below. Fosun Industrial Name Business Address Present Principal Employment Citizenship Chen Qiyu No. 1289 Yishan Road (Building A, Fosun Technology Park), Shanghai 200233 D

December 30, 2019 EX-11

Joint Filing Agreement by and among the Reporting Persons.

Exhibit 11 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of New Frontier Health Corporation, a Cayman Islands exempted company, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto.

December 30, 2019 SC 13D

NFC / New Frontier Corporation / Fosun Industrial Co., Ltd - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under Securities Exchange Act of 1934 (Amendment No. )* NEW FRONTIER HEALTH CORPORATION (Name of Issuer) Ordinary Shares, par value US$0.0001 per share (Title of Class of Securities) G6461G 106 (CUSIP Number) Liu Yongying Fosun Industrial Co., Limited Level 54 Hopewell Centre 183 Queen's Road East Hong Kong, China

December 30, 2019 EX-99.5

DIRECTOR NOMINATION AGREEMENT

Exhibit 99.5 DIRECTOR NOMINATION AGREEMENT THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of December 18, 2019 (the “Effective Time”), by and among New Frontier Corporation, an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), New Frontier Public Holding Ltd., an exempted company incorporated with limited liability under

December 26, 2019 F-3

NFC / New Frontier Corporation F-3 - - FORM F-3

As filed with the United States Securities and Exchange Commission on December 26, 2019 Registration No.

December 26, 2019 EX-2.1

Facilities Agreement, dated December 9, 2019, by and among NF Unicorn Chindex Holding Limited, China Merchants Bank Co., Ltd., New York Branch and Shanghai Pudong Development Bank Putuo Sub-Branch and Shanghai Pudong Development Bank Putuo Sub-Branch (incorporated by reference to Exhibit 2.1 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

Exhibit 2.1 EXECUTION VERSION FACILITIES AGREEMENT DATED 9 December 2019 for NF UNICORN CHINDEX HOLDING LIMITED as Company arranged by CHINA MERCHANTS BANK CO., LTD., NEW YORK BRANCH AND SHANGHAI PUDONG DEVELOPMENT BANK PUTUO SUB-BRANCH (上海浦东发展银行普陀支行) with SHANGHAI PUDONG DEVELOPMENT BANK PUTUO SUB-BRANCH (上海浦东发展银行普陀支行) as Agent and SHANGHAI PUDONG DEVELOPMENT BANK PUTUO SUB-BRANCH (上海浦东发展银行普陀支行)

December 26, 2019 EX-4.7

Employment Agreement, dated as of December 17, 2019, by and between the Company and Roberta Lipson (incorporated by reference to Exhibit 4.7 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

Exhibit 4.7 Execution Version EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Employment Agreement”), dated as of December 17, 2019 (the “Effective Date”), by and between New Frontier Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), and Roberta Lipson (“Employee”). WHEREAS, in connection with the transaction contemplated by

December 26, 2019 20FR12B

NFC / New Frontier Corporation 20FR12B - - FORM 20-F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ¨ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193

December 26, 2019 EX-4.8

Registration Rights Agreement, dated as of December 17, 2019, by and among the Company, Roberta Lipson and the other parties thereto (incorporated by reference to Exhibit 4.8 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

Exhibit 4.8 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement, dated as of December 17, 2019 (this “Agreement”), is made and entered into by and among New Frontier Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“NFC”), and the Founder Parties (as such term is defined in the Transaction Agreement among NFC, certain of its Su

December 26, 2019 EX-4.11

Fosun Director Nomination Agreement, dated as of December 18, 2019, by and among the Company, New Frontier Public Holding Ltd. and Fosun Industrial Co., Limited (incorporated by reference to Exhibit 4.11 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

EX-4.11 6 tm1927345d1ex4-11.htm EXHIBIT 4.11 Exhibit 4.11 CONFIDENTIAL EXECUTION VERSION DIRECTOR NOMINATION AGREEMENT THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of December 18, 2019 (the “Effective Time”), by and among New Frontier Corporation, an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), New Frontier Public

December 26, 2019 EX-4.12

Vivo Director Nomination Agreement, dated as of December 17, 2019, by and among the Company, New Frontier Public Holding Ltd. and Vivo Capital Fund IX (Cayman), L.P. (incorporated by reference to Exhibit 4.12 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

Exhibit 4.12 CONFIDENTIAL EXECUTION VERSION DIRECTOR NOMINATION AGREEMENT THIS DIRECTOR NOMINATION AGREEMENT (this “Agreement”) is made and entered into as of December 17, 2019 (the “Effective Time”), by and among New Frontier Corporation, an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), New Frontier Public Holding Ltd., an exempted company incorporate

December 26, 2019 EX-4.6

Amendment No. 1 to Founder Reinvestment Agreement, dated as of December 17, 2019, by and among NFC and the Lipson Parties (incorporated by reference to Exhibit 4.6 to the Company’s Shell Company Report on Form 20-F (File No. 001-38562), filed with the SEC on December 26, 2019).

Exhibit 4.6 AMENDMENT TO FOUNDER REINVESTMENT AGREEMENT This AMENDMENT TO FOUNDER REINVESTMENT AGREEMENT, dated as of December 17, 2019 (this “Amendment Agreement”) is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“NFC”); and (b) ROBERTA LIPSON, an individual acting in her personal cap

December 20, 2019 8-A12B/A

NFC / New Frontier Corporation 8-A12B/A - - 8-A12B/A

8-A12B/A 1 tm1926557d18a12ba.htm 8-A12B/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A/A (Amendment No. 1) FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 New Frontier Health Corporation (Exact name of registrant as specified in its charter) Cayman Islands 26-3828008 (State of incorporat

December 20, 2019 EX-4.2

Specimen Warrant Certificate (incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Company’s Form 8-A, filed with the SEC on December 20, 2019).

EX-4.2 4 tm1926557d1ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 [Form of Warrant Certificate] [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW New Frontier Health Corporation Incorporated Under the Laws of the Cayman Islands CUSIP G6461G 114 Warrant Certificate This Warrant Certificate cert

December 20, 2019 EX-3.1

Amended and Restated Memorandum of Association and Articles of Association of New Frontier Health Corporation (incorporated by reference to Exhibit 3.1 to Amendment No. 1 to the Company’s Form 8-A, filed with the SEC on December 20, 2019).

EX-3.1 2 tm1926557d1ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF New Frontier HEALTH Corporation (adopted by special resolution dated 17 DECEMBER 2019) THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM

December 20, 2019 6-K

NFC / New Frontier Corporation 6-K - Current Report of Foreign Issuer - FORM 6-K

FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of December, 2019 Commission File Number: 001-38562 NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English) 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong (Address of principal

December 20, 2019 EX-4.1

Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Company’s Form 8-A, filed with the SEC on December 20, 2019).

Exhibit 4.1 NUMBER SHARES C- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP G6461G 106 NEW FRONTIER HEALTH CORPORATION ORDINARY SHARES THIS CERTIFIES THAT is the owner of Ordinary shares, par value $0.0001 per share (each, a “Ordinary Share”), of New Frontier Health Corporation, a Cayman Islands exempted company (the “Company”), transferable on the books of the Company in person or by duly authorized a

December 20, 2019 EX-10.5

Registration Rights Agreement, dated as of December 17, 2019, by and among the Company, Roberta Lipson and the other parties listed on the signature pages thereto.

Exhibit 10.5 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement, dated as of December 17, 2019 (this “Agreement”), is made and entered into by and among New Frontier Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“NFC”), and the Founder Parties (as such term is defined in the Transaction Agreement among NFC, certain of its S

December 20, 2019 EX-99.1

New Frontier Corporation Completes Acquisition of United Family Healthcare Combined company renamed New Frontier Health Corporation and will trade on The New York Stock Exchange under “NFH”

EX-99.1 2 tm1926623d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Corporation Completes Acquisition of United Family Healthcare Combined company renamed New Frontier Health Corporation and will trade on The New York Stock Exchange under “NFH” Hong Kong, December 19, 2019 – New Frontier Corporation (NYSE: NFC) (“NFC”), a public investment vehicle sponsored by New Frontier Group, announced toda

December 19, 2019 EX-99.25

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 30, 2019, pursuant to the provisions of Rule 12d2-2 (a).

December 12, 2019 EX-99.1

New Frontier Corporation Shareholders Approve Business Combination with United Family Healthcare Combined company to be renamed New Frontier Health Corporation and will continue to be listed on The New York Stock Exchange

Exhibit 99.1 New Frontier Corporation Shareholders Approve Business Combination with United Family Healthcare Combined company to be renamed New Frontier Health Corporation and will continue to be listed on The New York Stock Exchange Hong Kong, December 12, 2019 – New Frontier Corporation (NYSE: NFC) (“NFC”), a publicly traded special purpose acquisition company, today announced that its sharehol

December 12, 2019 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissi

December 6, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission

December 6, 2019 8-K

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 5, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissio

December 2, 2019 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissio

December 2, 2019 EX-99.1

New Frontier Corporation Announces Date of Extraordinary General Meeting to Approve Business Combination with United Family Healthcare Meeting Scheduled for December 12, 2019

Exhibit 99.1 New Frontier Corporation Announces Date of Extraordinary General Meeting to Approve Business Combination with United Family Healthcare Meeting Scheduled for December 12, 2019 Hong Kong, December 2, 2019 – New Frontier Corporation (NYSE: NFC) (“NFC”) announced today that it has scheduled its extraordinary general meeting of shareholders (“Extraordinary General Meeting”) for Thursday, D

December 2, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissio

December 2, 2019 EX-99.1

Press Release, dated December 2, 2019.

EX-99.1 2 tm1924293d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Corporation Announces Date of Extraordinary General Meeting to Approve Business Combination with United Family Healthcare Meeting Scheduled for December 12, 2019 Hong Kong, December 2, 2019 – New Frontier Corporation (NYSE: NFC) (“NFC”) announced today that it has scheduled its extraordinary general meeting of shareholders (“Ex

November 29, 2019 DEFM14A

Definitive Proxy Statement on Schedule 14A with respect to the business combination filed with the SEC on November 27, 2019

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use

November 22, 2019 CORRESP

NFC / New Frontier Corporation CORRESP - -

JOEL L. RUBINSTEIN Partner (212) 294-5336 [email protected] November 22, 2019 VIA EDGAR AND HAND DELIVERY U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Paul Fischer Re: New Frontier Corporation Preliminary Proxy Materials on Schedule PreR14A Filed on November 12, 2019 File No. 001-38562 Dear Mr. Fischer: On behalf

November 22, 2019 PRER14A

NFC / New Frontier Corporation PRER14A - - PRER14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment No. 3) Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Con

November 14, 2019 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38562 NEW FR

November 12, 2019 PRER14A

NFC / New Frontier Corporation PRER14A - - PRER14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment No. 2) Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Con

November 12, 2019 CORRESP

NFC / New Frontier Corporation CORRESP - -

CORRESP 1 filename1.htm JOEL L. RUBINSTEIN Partner (212) 294-5336 [email protected] November 12, 2019 VIA EDGAR AND HAND DELIVERY U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Paul Fischer Re: New Frontier Corporation Preliminary Proxy Materials on Schedule PreR14A Filed October 25, 2019 File No. 001-38562 Dear Mr.

November 6, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of

November 6, 2019 EX-99.1

1 Nov 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 23:00PM Nov 1st, 2019

Exhibit 99.1 1 Nov 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 23:00PM Nov 1st, 2019 2 2 DISCLAIMER This investor presentation (“presentation”) is for informational purposes only and does not constitute an offer to sell, a so lic itation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments of New Frontier C

November 6, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 tm1921835d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdic

October 25, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of

October 25, 2019 EX-99.1

New Frontier Corporation and United Family Healthcare Announce First Half 2019 Financial Results for United Family Healthcare

EX-99.1 2 tm1920971d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Corporation and United Family Healthcare Announce First Half 2019 Financial Results for United Family Healthcare HONG KONG – (October 25, 2019) – New Frontier Corporation (NYSE: NFC) (“NFC”), a publicly traded special purpose acquisition company, and United Family Healthcare (“UFH”), a leading private healthcare provider offeri

October 25, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissio

October 25, 2019 PRER14A

NFC / New Frontier Corporation PRER14A - - PRER14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Amendment No. 1) Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Con

October 25, 2019 CORRESP

NFC / New Frontier Corporation CORRESP - -

Joel L. Rubinstein Partner (212) 294-5336 [email protected] October 25, 2019 VIA EDGAR AND HAND DELIVERY U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Mr. Paul Fischer Re: New Frontier Corporation Preliminary Proxy Statement on Schedule 14A Filed September 11, 2019 File No. 001-38562 Dear Mr. Fischer: On behalf of our

September 11, 2019 PREM14A

NFC / New Frontier Corporation PREM14A - - PREM14A

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Information Required in Proxy Statement Schedule 14A Information Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use

September 9, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of

September 9, 2019 EX-99.1

1 Sep 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 10:00AM Sep 9th, 2019

EX-99.1 2 tv529051ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 Sep 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 10:00AM Sep 9th, 2019 2 2 DISCLAIMER This investor presentation (“presentation”) is for informational purposes only and does not constitute an offer to sell, a so lic itation of an offer to buy, or a recommendation to purchase any equity, debt or oth

September 9, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commissi

August 14, 2019 10-Q

NFC / New Frontier Corporation 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38562 NEW FRONTIE

August 1, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of

August 1, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 tv5263868k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction o

August 1, 2019 EX-99.1

New Frontier Corporation Acquisition of United Family Healthcare Conference Call Script

Exhibit 99.1 New Frontier Corporation Acquisition of United Family Healthcare Conference Call Script Operator: Ladies and gentlemen, welcome to the New Frontier Corporation and United Family Healthcare conference call. All participants will be in listen-only mode, and there will not be a question-and-answer session. Today’s conference is being recorded. At this time, I would like to turn the call

July 30, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

8-K 1 tv5260858k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction o

July 30, 2019 EX-2.1

Transaction Agreement, dated as of July 30, 2019, by and among the Company, NFC Buyer Sub, Healthy Harmony, HH GP and the Sellers (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 001-38562) filed with the SEC on July 30, 2019).

Exhibit 2.1 EXECUTION VERSION TRANSACTION AGREEMENT by and among NEW FRONTIER CORPORATION, NF UNICORN ACQUISITION L.P., HEALTHY HARMONY HOLDINGS, L.P., HEALTHY HARMONY GP, INC. and THE SELLERS NAMED HEREIN Dated as of July 30, 2019 TABLE OF CONTENTS Page Article I DEFINITIONS 6 Section 1.1 Certain Definitions 6 Section 1.2 Other Defined Terms 19 Section 1.3 Interpretation and Rules of Construction

July 30, 2019 EX-10.6

Commitment Letter, dated June 14, 2019, by and between NF Unicorn and Shanghai Pudong Development Bank Putuo Sub-Branch (incorporated by reference to Exhibit 10.6 to the Registrant’s Current Report on Form 8-K filed with the SEC on July 30, 2019).

Exhibit 10.6 EXECUTION VERSION To: NF Unicorn Acquisition Limited (you or the Company) 14 June 2019 Dear Sirs, Project Unicorn – Commitment Letter We, Shanghai Pudong Development Bank Putuo Sub-Branch (the Original Arranger) and Shanghai Pudong Development Bank Putuo Sub-Branch (the Original Underwriter, and together with the Original Arranger, we or us) are pleased to set out in this letter the t

July 30, 2019 EX-10.7

Form of Support Agreement, by and between HH GP and certain shareholders of NFC.

EX-10.7 9 tv526085ex10-7.htm FORM OF SUPPORT AGREEMENT, BY AND BETWEEN HH GP AND CERTAIN SHAREHOLDERS OF NFC. Exhibit 10.7 EXECUTION VERSION SUPPORT AGREEMENT This SUPPORT AGREEMENT, dated as of [●], 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, the “Agreement”), is made and entered into by and among: (a) HEALTHY HARMONY GP, INC.,

July 30, 2019 EX-10.5

Agreement, dated as of July 30, 2019, by and among Vivo Capital Fund IX (Cayman), L.P., New Frontier Public Holding Ltd., the Company, Antony Leung and Carl Wu (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K (File No. 001-38562) filed with the SEC on July 30, 2019).

EX-10.5 7 tv526085ex10-5.htm AGREEMENT, DATED AS OF JULY 30, 2019, BY AND AMONG VIVO, THE SPONSOR, NFC, ANTONY LEUNG AND CARL WU. Exhibit 10.5 EXECUTION VERSION AGREEMENT This AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) Vivo Capital Fun

July 30, 2019 EX-10.1

Founder Reinvestment Agreement, dated as of July 30, 2019, by and among NFC and the Lipson Parties (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-38562) filed with the SEC on July 30, 2019).

Exhibit 10.1 EXECUTION VERSION FOUNDER REINVESTMENT AGREEMENT This FOUNDER REINVESTMENT AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the

July 30, 2019 EX-10.3

Fosun Voting Undertaking, dated as of July 30, 2019, delivered by Fosun High Tech to NFC and HH GP.

Exhibit 10.3 EXECUTION VERSION VOTING UNDERTAKING This VOTING UNDERTAKING, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Undertaking”), is made by SHANGHAI FOSUN HIGH TECHNOLOGY (GROUP) CO., LTD. (上海复星高科技 (集团) 有限公司), a limited liability company incorporated under the laws of the PRC (“Fosun High Tech”),

July 30, 2019 EX-10.4

Form of Subscription Agreement, by and between the Company and certain institutions and accredited investors (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K (File No. 001-38562) filed with the SEC on July 30, 2019).

Exhibit 10.4 EXECUTION VERSION SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Subscription Agreement”), dated as of [●], 2019 is made and entered into by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and the investor named on the signature page hereof (“Investor”). Capitalized terms used but not otherwise defined in this Subscription Agreement

July 30, 2019 EX-10.2

Fosun Rollover Agreement, dated as of July 30, 2019, by and between the Company and Fosun Industrial Co., Limited, (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-38562) filed with the SEC on July 30, 2019).

Exhibit 10.2 EXECUTION VERSION FOSUN ROLLOVER AGREEMENT This FOSUN ROLLOVER AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the Cayman Islan

July 30, 2019 EX-10.1

Founder Reinvestment Agreement, dated as of July 30, 2019, by and among NFC and the Lipson Parties.

Exhibit 10.1 EXECUTION VERSION FOUNDER REINVESTMENT AGREEMENT This FOUNDER REINVESTMENT AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the

July 30, 2019 EX-10.5

Agreement, dated as of July 30, 2019, by and among Vivo, the Sponsor, NFC, Antony Leung and Carl Wu.

EX-10.5 7 tv526085ex10-5.htm AGREEMENT, DATED AS OF JULY 30, 2019, BY AND AMONG VIVO, THE SPONSOR, NFC, ANTONY LEUNG AND CARL WU. Exhibit 10.5 EXECUTION VERSION AGREEMENT This AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) Vivo Capital Fun

July 30, 2019 EX-2.1

Transaction Agreement, dated as of July 30, 2019, by and among NFC, NFC Buyer Sub, Healthy Harmony, HH GP and the Sellers.

EX-2.1 2 tv526085ex2-1.htm TRANSACTION AGREEMENT, DATED AS OF JULY 30, 2019, BY AND AMONG NFC, NFC BUYER SUB, HEALTHY HARMONY, HH GP AND THE SELLERS. Exhibit 2.1 EXECUTION VERSION TRANSACTION AGREEMENT by and among NEW FRONTIER CORPORATION, NF UNICORN ACQUISITION L.P., HEALTHY HARMONY HOLDINGS, L.P., HEALTHY HARMONY GP, INC. and THE SELLERS NAMED HEREIN Dated as of July 30, 2019 TABLE OF CONTENTS

July 30, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commission F

July 30, 2019 EX-10.6

Commitment Letter, dated June 14, 2019, by and between NF Unicorn and Shanghai Pudong Development Bank Putuo Sub-Branch.

Exhibit 10.6 EXECUTION VERSION To: NF Unicorn Acquisition Limited (you or the Company) 14 June 2019 Dear Sirs, Project Unicorn – Commitment Letter We, Shanghai Pudong Development Bank Putuo Sub-Branch (the Original Arranger) and Shanghai Pudong Development Bank Putuo Sub-Branch (the Original Underwriter, and together with the Original Arranger, we or us) are pleased to set out in this letter the t

July 30, 2019 EX-10.2

Fosun Rollover Agreement, dated as of July 30, 2019, by and between NFC and Fosun Seller.

Exhibit 10.2 EXECUTION VERSION FOSUN ROLLOVER AGREEMENT This FOSUN ROLLOVER AGREEMENT, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Agreement”), is made and entered into by and among: (a) NEW FRONTIER CORPORATION, an exempted company incorporated with limited liability under the laws of the Cayman Islan

July 30, 2019 EX-10.3

Fosun Voting Undertaking, dated as of July 30, 2019, delivered by Fosun High Tech to NFC and HH GP.

Exhibit 10.3 EXECUTION VERSION VOTING UNDERTAKING This VOTING UNDERTAKING, dated as of July 30, 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, this “Undertaking”), is made by SHANGHAI FOSUN HIGH TECHNOLOGY (GROUP) CO., LTD. (上海复星高科技 (集团) 有限公司), a limited liability company incorporated under the laws of the PRC (“Fosun High Tech”),

July 30, 2019 EX-10.7

Form of Support Agreement, by and between HH GP and certain shareholders of NFC.

Exhibit 10.7 EXECUTION VERSION SUPPORT AGREEMENT This SUPPORT AGREEMENT, dated as of [●], 2019 (as may be amended, supplemented, modified and varied from time to time in accordance with the terms herein, the “Agreement”), is made and entered into by and among: (a) HEALTHY HARMONY GP, INC., an exempted company incorporated with limited liability under the laws of the Cayman Islands and the general

July 30, 2019 EX-10.4

Form of Subscription Agreement, by and between NFC and certain institutions and accredited investors.

Exhibit 10.4 EXECUTION VERSION SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Subscription Agreement”), dated as of [●], 2019 is made and entered into by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and the investor named on the signature page hereof (“Investor”). Capitalized terms used but not otherwise defined in this Subscription Agreement

July 30, 2019 DEFA14A

NFC / New Frontier Corporation DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of

July 30, 2019 EX-99.1

NEW FRONTIER CORPORATION TO ACQUIRE UNITED FAMILY HEALTHCARE TO CREATE ONE OF CHINA’S LARGEST PUBLICLY LISTED INTEGRATED PRIVATE HEALTHCARE SERVICES COMPANY

Exhibit 99.1 NEW FRONTIER CORPORATION TO ACQUIRE UNITED FAMILY HEALTHCARE TO CREATE ONE OF CHINA’S LARGEST PUBLICLY LISTED INTEGRATED PRIVATE HEALTHCARE SERVICES COMPANY Hong Kong, July 30, 2019 — New Frontier Corporation (NYSE: NFC) (“NFC”), a public investment vehicle sponsored by New Frontier Group, and United Family Healthcare (“UFH”), one of the largest and most recognized integrated premium

July 30, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2019 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commission F

July 30, 2019 EX-99.2

1 July 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 16:00PM Jul 30, 2019 To remove this and all watermarks

Exhibit 99.2 1 July 2019 New Frontier Corporation Business Combination with United Family Healthcare Updated 16:00PM Jul 30, 2019 To remove this and all watermarks 2 2 DISCLAIMER This investor presentation (“presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financi

May 15, 2019 10-Q

NFC / New Frontier Corporation Class A 10-Q Quarterly Report FORM 10-Q

10-Q 1 tv52096610q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

April 1, 2019 10-K

NFC / New Frontier Corporation Class A FORM 10-K (Annual Report)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-385

February 14, 2019 SC 13G

NFC / New Frontier Corporation / OXFORD ASSET MANAGEMENT - OXFORD ASSET MANAGEMENT LLP Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NEW FRONTIER CORP (Name of Issuer) Class A ordinary shares, par value $0.0001 (Title of Class of Securities) G6485P108 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

November 13, 2018 10-Q

NFC / New Frontier Corporation Class A FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to NEW FRONTIER CORPORATION (Exact name of registrant

August 13, 2018 10-Q

NFC / New Frontier Corporation Class A FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to NEW FRONTIER CORPORATION (Exact name of registrant as s

July 24, 2018 EX-99.1

New Frontier Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 27, 2018

EX-99.1 2 tv499144ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 New Frontier Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 27, 2018 July 24, 2018 HONG KONG—(BUSINESS WIRE)—New Frontier Corporation (NYSE: NFC.U) (the “Company”) announced that, commencing July 27, 2018, holders of the units sold in the Company’s initial public offering of 28,750,000 u

July 24, 2018 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2018 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commission F

July 10, 2018 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 3, 2018 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commission Fi

July 10, 2018 EX-99.1

NEW FRONTIER CORPORATION   BALANCE SHEET July 3, 2018

Exhibit 99.1 NEW FRONTIER CORPORATION INDEX TO FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm F-2 Balance Sheet F-3 Notes to Balance Sheet F-4 Report of Independent Registered Public Accounting Firm Opinion on the Financial Statement We have audited the accompanying balance sheet of New Frontier Corporation (the ?Company?) as of July 3, 2018, and the related notes (co

July 9, 2018 EX-11

Joint Filing Agreement by and among the Reporting Persons.

Exhibit 11 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of New Frontier Corporation, a Cayman Islands exempted company, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto.

July 9, 2018 SC 13D

NFC / New Frontier Corporation / New Frontier Public Holding Ltd. - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NEW FRONTIER CORPORATION (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) G6485P 108 (CUSIP Number) Carl Wu New Frontier Public Holding Ltd. 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong 852-6491-9230 Copy to: Joel L. Rubinstein Winston

July 3, 2018 EX-1.1

Underwriting Agreement, dated June 27, 2018, by and between the Company and Credit Suisse Securities (USA) LLC and UBS Securities LLC, as representatives of the several underwriters.

EX-1.1 2 tv497952ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 25,000,000 Units New Frontier Corporation UNDERWRITING AGREEMENT June 27, 2018 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, N.Y. 10010 UBS Securities LLC 1285 Avenue of the Americas New York, N.Y. 10019 As Representatives of the several Underwriters listed in Schedule I-A and Schedule I-B to the Agreement Dear Sirs and Madame

July 3, 2018 EX-10.8

Indemnity Agreement, dated June 27, 2018, by and between the Company and Edward Leong Che-hung.

EX-10.8 11 tv497952ex10-8.htm EXHIBIT 10.8 Exhibit 10.8 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and Edward Leong Che-hung (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as director

July 3, 2018 EX-4.1

Warrant Agreement, dated June 27, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1. to the Company’s Current Report on Form 8-K (File No. 001-38562), filed with the SEC on July 3, 2018).

Exhibit 4.1 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of June 27, 2018, is by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?). WHEREAS, the Company has entered into that certain Private Placement Warran

July 3, 2018 EX-10.9

Indemnity Agreement, dated June 27, 2018, by and between the Company and Frederick Ma Si-hang.

EX-10.9 12 tv497952ex10-9.htm EXHIBIT 10.9 Exhibit 10.9 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and Frederick Ma Si-hang (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors

July 3, 2018 EX-10.2

Investment Management Trust Agreement, dated June 27, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of June 27, 2018 by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No. 3

July 3, 2018 EX-10.10

Indemnity Agreement, dated June 27, 2018, by and between the Company and Shuo Wang.

EX-10.10 13 tv497952ex10-10.htm EXHIBIT 10.10 Exhibit 10.10 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and Shuo Wang (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, offic

July 3, 2018 EX-10.4

Private Placement Warrants Purchase Agreement, dated June 27, 2018, between the Issuer and the Sponsor (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed by the Issuer on July 3, 2018 (File No. 001-38562)).

Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of June 27, 2018 (as it may from time to time be amended, this ?Agreement?), is entered into by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and New Frontier Public Holding Ltd., a Cayman Islands exempted company (the ?Sponsor? or the ?

July 3, 2018 EX-10.7

Indemnity Agreement, dated June 27, 2018, by and between the Company and David Johnson.

Exhibit 10.7 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and David Johnson (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are

July 3, 2018 EX-10.1

Letter Agreement, dated June 27, 2018, by and among the Company, its executive officers, its directors and New Frontier Public Holding Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-38562), filed with the SEC on July 3, 2018).

EX-10.1 4 tv497952ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 June 27, 2018 New Frontier Corporation 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and among New Frontier Corporation

July 3, 2018 EX-10.11

Administrative Services Agreement, dated June 27, 2018, by and between the Company and New Frontier Capital II Ltd.

Exhibit 10.11 NEW FRONTIER CORPORATION 23rd Floor, 299 QRC 287-299 Queen?s Road Central Hong Kong June 27, 2018 New Frontier Capital II Ltd. 23rd Floor, 299 QRC 287-299 Queen?s Road Central Hong Kong Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreement (this ?Agreement?) by and between New Frontier Corporation (the ?Company?) and New Frontier Capital II Ltd. (the ?Prov

July 3, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 27, 2018 NEW FRONTIER CORPORATION (Exact name of registrant as specified in its charter) Cayman Islands 001-38562 N/A (State or other jurisdiction of incorporation) (Commission F

July 3, 2018 EX-10.3

Registration Rights Agreement, dated June 27, 2018, by and between the Company and New Frontier Public Holding Ltd. (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K (File No. 001-38562), filed with the SEC on July 3, 2018).

EX-10.3 6 tv497952ex10-3.htm EXHIBIT 10.3 Exhibit 10.3 EXECUTION VERSION REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 27, 2018, is made and entered into by and among New Frontier Corporation, a Cayman Islands exempted company (the “Company”), New Frontier Public Holding Ltd., a Cayman Islands exempted company (the “Sponsor”), and the undersi

July 3, 2018 EX-10.6

Indemnity Agreement, dated June 27, 2018, by and between the Company and Carl Wu.

Exhibit 10.6 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Carl Wu (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provid

July 3, 2018 EX-10.5

Indemnity Agreement, dated June 27, 2018, by and between the Company and Antony Leung.

Exhibit 10.5 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this ?Agreement?) is made as of June 27, 2018, by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Antony Leung (?Indemnitee?). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are p

July 3, 2018 EX-99.1

New Frontier Corporation Announces Pricing of Initial Public Offering

Exhibit 99.1 New Frontier Corporation Announces Pricing of Initial Public Offering New Frontier Corporation Announces Pricing of Initial Public Offering and Committed Capital Raise of up to $468.5 Million in the Aggregate, Comprised of a $250 Million Initial Public Offering (up to $287.5 Million if the Underwriters Exercise their Over-allotment Option in Full), plus $181 Million in Committed Capit

June 29, 2018 424B4

$250,000,000 New Frontier Corporation 25,000,000 Units

TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4) ?Registration Nos. 333-225421 and 333-225940? PROSPECTUS $250,000,000 New Frontier Corporation 25,000,000 Units New Frontier Corporation is a newly incorporated blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more

June 27, 2018 S-1MEF

As filed with the U.S. Securities and Exchange Commission on June 27, 2018.

? As filed with the U.S. Securities and Exchange Commission on June 27, 2018. Registration No. 333-??????? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ? New Frontier Corporation (Exact name of registrant as specified in its charter) ? ? Cayman Islands ? ? 6770 ? ? N/A ? ? (State or Other Jurisdiction

June 26, 2018 8-A12B

June 26, 2018

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 New Frontier Corporation (Exact name of registrant as specified in its charter) Cayman Islands (State of incorporation or organization) N/A (I.R.S. Employer Identification No.) 23rd Floor, 299 QR

June 25, 2018 CORRESP

[Signature Page Follows]

June 25, 2018 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010 UBS Securities LLC 299 Park Avenue New York, New York 10019 VIA EDGAR U.

June 25, 2018 CORRESP

New Frontier Corporation 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong

New Frontier Corporation 23rd Floor, 299 QRC 287-299 Queen?s Road Central Hong Kong June 25, 2018 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance U.

June 22, 2018 S-1/A

As filed with the U.S. Securities and Exchange Commission on June 22, 2018.

TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on June 22, 2018. Registration No. 333-225421? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ? New Frontier Corporation (Exact name of registrant as specified in its charter) ? ? Cayman Islands ? ? 6770 ? ? N

June 22, 2018 CORRESP

Joel L. Rubinstein

Joel L. Rubinstein Partner 212 294-5336 [email protected] June 22, 2018 VIA EDGAR AND HAND DELIVERY Kim McManus Senior Attorney Office of Real Estate and Commodities United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mail Stop 3233 Washington, D.C. 20549 Re: New Frontier Corporation Amendment No. 2 to Registration Statement on Form S-1 Filed

June 22, 2018 EX-10.10

Deed of Waiver to Forward Purchase Agreements, effective as of June 22, 2018.

Exhibit 10.10 DEED OF WAIVER TO FORWARD PURCHASE AGREEMENT Effective as of June 22, 2018 Reference is hereby made to those certain Forward Purchase Agreements (the ?Agreements?), effective as of June 4, 2018, by and among New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), New Frontier Public Holding Ltd., a Cayman Islands exempted company (the ?Sponsor?), and the purchase

June 20, 2018 EX-3.2

Amended and Restated Memorandum and Articles of Association.

EX-3.2 3 tv496367ex3-2.htm AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Exhibit 3.2 THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF New Frontier Corporation (adopted by special resolution dated June 14, 2018) THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHAR

June 20, 2018 S-1/A

As filed with the U.S. Securities and Exchange Commission on June 20, 2018.

TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on June 20, 2018. Registration No. 333-225421? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ? New Frontier Corporation (Exact name of registrant as specified in its charter) ? ? Cayman Islands ? ? 6770 ? ? N

June 20, 2018 EX-99.3

Consent of David Lawrence Johnson.

EX-99.3 15 tv496367ex99-3.htm CONSENT OF DAVID LAWRENCE JOHNSON Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by New Frontier Corporation of the Registration Statement on Form S-1/A with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to b

June 20, 2018 EX-10.3

Form of Registration Rights Agreement among the Registrant, New Frontier Public Holding

EX-10.3 9 tv496367ex10-3.htm FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT, NEW FRONTIER PUBLIC HOLDING LTD. AND THE HOLDERS SIGNATORY THERETO Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [], 2018, is made and entered into by and among New Frontier Corporation, a Cayman Islands exempted company (the “Company”), New Front

June 20, 2018 EX-10.1

Form of Letter Agreement among the Registrant, New Frontier Public Holding Ltd. and each of the directors and executive officers of the Registrant.

Exhibit 10.1 [], 2018 New Frontier Corporation 23rd Floor, 299 QRC 287-299 Queen?s Road Central Hong Kong Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) to be entered into by and among New Frontier Corporation, a Cayman Islands exempted company (the ?Compa

June 20, 2018 EX-10.4

Form of Private Placement Warrants Purchase Agreement between the Registrant and the Holders signatory thereto.

Exhibit 10.4 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [?], 2018 (as it may from time to time be amended, this ?Agreement?), is entered into by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and New Frontier Public Holding Ltd., a Cayman Islands exempted company (the ?Sponsor? or the ?Purc

June 20, 2018 EX-14

Code of Business Conduct and Ethics (incorporated by reference to Exhibit 14 to the Company’s Registration Statement on Form S-1/A (File No. 333-225421), filed with SEC on June 20, 2018).

Exhibit 14 CODE OF BUSINESS CONDUCT AND ETHICS OF NEW FRONTIER CORPORATION EFFECTIVE [], 2018 1.

June 20, 2018 CORRESP

Joel L. Rubinstein

Joel L. Rubinstein Partner 212 294-5336 [email protected] June 20, 2018 VIA EDGAR AND HAND DELIVERY Kim McManus Senior Attorney Office of Real Estate and Commodities United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mail Stop 3233 Washington, D.C. 20549 Re: New Frontier Corporation Registration Statement on Form S-1 Filed June 4, 2018 Amendm

June 20, 2018 EX-10.8

Form of Administrative Services Agreement between the Registrant and New Frontier Capital II Ltd.

EX-10.8 11 tv496367ex10-8.htm FORM OF ADMINISTRATIVE SERVICES AGREEMENT BETWEEN THE REGISTRANT AND NEW FRONTIER CAPITAL II LTD. Exhibit 10.8 NEW FRONTIER CORPORATION 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong , 2018 New Frontier Capital II Ltd. 23rd Floor, 299 QRC 287-299 Queen’s Road Central Hong Kong Re: Administrative Services Agreement Ladies and Gentlemen: This letter agreemen

June 20, 2018 EX-10.2

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this ?Agreement?) is made effective as of [], 2018 by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation (the ?Trustee?). WHEREAS, the Company?s registration statement on Form S-1, File No. 333-22

June 20, 2018 EX-10.9

Form of Forward Purchase Agreement, dated as of June 4, 2018, between the Registrant, New Frontier Public Holding Ltd. and the party listed on the signature page thereto (incorporated by reference to Exhibit 10.9 to the Company’s Registration Statement on Form S-1/A (File No. 333-225421), filed with the SEC on June 20, 2018).

Exhibit 10.9 EXECUTION COPY FORWARD PURCHASE AGREEMENT This Forward Purchase Agreement (this “Agreement”) is entered into as of June 4, 2018, between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), New Frontier Public Holding Ltd., a Cayman Islands exempted company (the “Sponsor”) and the party listed as the purchaser on the signature page hereof (the “Purchaser”). Rec

June 20, 2018 EX-4.4

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of [], 2018, is by and between New Frontier Corporation, a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”). WHEREAS, the Company has entered into that certain Private Placement Warrants Pu

June 20, 2018 EX-1.1

Form of Underwriting Agreement.

Exhibit 1.1 23,000,000 Units New Frontier Corporation UNDERWRITING AGREEMENT [•], 2018 Credit Suisse Securities (USA) LLC Eleven Madison Avenue, New York, N.Y. 10010 UBS Securities LLC 1285 Avenue of the Americas New York, N.Y. 10019 As Representatives of the several Underwriters listed in Schedule I-A and Schedule I-B to the Agreement Dear Sirs and Madames: 1. Introductory. New Frontier Corporati

June 14, 2018 EX-3.2

Form of Amended and Restated Memorandum and Articles of Association.

Exhibit 3.2 THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF New Frontier Corporation (adopted by special resolution dated [ ] 2018) THE COMPANIES LAW (2018 Revision) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF New Frontier Corporation (adopted by sp

June 14, 2018 EX-4.4

Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant.

Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this ?Agreement?), dated as of [], 2018, is by and between New Frontier Corporation, a Cayman Islands exempted company (the ?Company?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the ?Warrant Agent?). WHEREAS, the Company has entered into that certain Private Placement Warrants Pu

June 14, 2018 EX-10.1

Form of Letter Agreement among the Registrant, New Frontier Public Holding Ltd. and each of the directors and officers of the Registrant.

Exhibit 10.1 [], 2018 New Frontier Corporation 23rd Floor, 299 QRC 287-299 Queen?s Road Central Hong Kong Re: Initial Public Offering Ladies and Gentlemen: This letter (this ?Letter Agreement?) is being delivered to you in accordance with the Underwriting Agreement (the ?Underwriting Agreement?) to be entered into by and among New Frontier Corporation, a Cayman Islands exempted company (the ?Compa

June 14, 2018 S-1/A

As filed with the U.S. Securities and Exchange Commission on June 13, 2018.

? As filed with the U.S. Securities and Exchange Commission on June 13, 2018. Registration No. 333-225421? ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ? AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ? New Frontier Corporation (Exact name of registrant as specified in its charter) ? ? Cayman Islands ? ? 6770 ? ? N/A ? ? (State or

June 14, 2018 EX-4.3

Specimen Warrant Certificate.*

Exhibit 4.3 [Form of Warrant Certificate] [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW New Frontier Corporation Incorporated Under the Laws of the Cayman Islands CUSIP [?] Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the registered ho

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista